New Medicines in Development
Today, over 2,900 new medicines are in development. Many of these potential new medicines will fail in clinical trials, but some may represent tomorrow's new treatments. Bringing each new medicine to patients will require, on average, 10 to 15 years of testing and review.
This database includes medicines currently in clinical trials or at FDA for review. The information contained in this database was derived from Wolters Kluwer Health's Adis R&D Insight database and is published with permission under license with Wolters Kluwer Health. PhRMA has not reviewed or verified this information.
Explore our database of new medicines in development and find out what the future may hold.
Diabetes
A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found that there are a record 183 new diabetes medicines currently in development to help treat diabetes (read more).
Rare Diseases
There are more than 300 medicines currently in development to treat or prevent hundreds of rare diseases, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). Genetic Alliance and the National Organization for Rare Disorders (NORD) joined PhRMA in releasing the report (read more).
Cancer
There are 861 medicines in development to treat patients with cancer, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). These treatments include 122 for lung cancer and 107 for breast cancer (read more).
Heart Disease and Stroke
A record number of potential medicines to treat heart disease and stroke are being developed, according to the latest report by the Pharmaceutical Research and Manufacturers of America (PhRMA) on medicines in the research pipeline (read more).
Neurological Conditions
A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found that America’s pharmaceutical research companies are testing 547 new medicines to help treat neurological conditions. Learn more about potential medicines for Alzheimer's, Parkinson’s, epilepsy, sleep disorders, brain tumors, and many others (read more).
Mental Health Disorders
More than 300 medicines are in development to help treat mental an estimated 60 million American adults who suffer from mental health disorders (read more).
Older Americans
More than 2,000 medicines for older Americans are currently being tested in clinical trials or are waiting for Food and Drug Administration approval, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) (read more).
HIV/AIDS
Pharmaceutical researchers are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) (read more).
Women
More than 700 medicines for diseases that disproportionately or only affect women are currently in development, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) (read more).
Children
A new report by the Pharmaceutical Research and Manufacturers of America (PhRMA) finds that biopharmaceutical researchers are testing 219 medicines to help meet the special healthcare needs of children (read more).
Biotechnology Medicines
A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) found that America’s pharmaceutical research and biotechnology companies are testing a record 633 new biotech medicines (read more).
.gif)